Logo image of SAN.PA

SANOFI (SAN.PA) Stock Fundamental Analysis

Europe - EPA:SAN - FR0000120578 - Common Stock

89.59 EUR
-0.85 (-0.94%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SAN. SAN was compared to 54 industry peers in the Pharmaceuticals industry. SAN has an excellent profitability rating, but there are some minor concerns on its financial health. SAN is not valued too expensively and it also shows a decent growth rate. SAN also has an excellent dividend rating. These ratings could make SAN a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SAN had positive earnings in the past year.
In the past year SAN had a positive cash flow from operations.
SAN had positive earnings in each of the past 5 years.
In the past 5 years SAN always reported a positive cash flow from operatings.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of 11.05%, SAN is in the better half of the industry, outperforming 75.93% of the companies in the same industry.
SAN has a better Return On Equity (19.73%) than 64.81% of its industry peers.
With a decent Return On Invested Capital value of 13.84%, SAN is doing good in the industry, outperforming 68.52% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SAN is significantly below the industry average of 14.51%.
The last Return On Invested Capital (13.84%) for SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROIC 13.84%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 20.35%, SAN is doing good in the industry, outperforming 77.78% of the companies in the same industry.
SAN's Profit Margin has improved in the last couple of years.
The Operating Margin of SAN (23.59%) is comparable to the rest of the industry.
SAN's Operating Margin has improved in the last couple of years.
SAN has a Gross Margin of 71.70%. This is comparable to the rest of the industry: SAN outperforms 53.70% of its industry peers.
In the last couple of years the Gross Margin of SAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SAN is still creating some value.
Compared to 1 year ago, SAN has about the same amount of shares outstanding.
The number of shares outstanding for SAN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, SAN has an improved debt to assets ratio.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

SAN has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SAN would need 2.21 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.21, SAN belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
SAN has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.21, SAN is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Altman-Z N/A
ROIC/WACC1.79
WACC7.73%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.27 indicates that SAN should not have too much problems paying its short term obligations.
SAN has a Current ratio (1.27) which is in line with its industry peers.
SAN has a Quick Ratio of 1.27. This is a bad value and indicates that SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
SAN's Quick ratio of 0.94 is in line compared to the rest of the industry. SAN outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.94
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

The earnings per share for SAN have decreased by -5.35% in the last year.
SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%

3.2 Future

Based on estimates for the next years, SAN will show a small growth in Earnings Per Share. The EPS will grow by 7.06% on average per year.
Based on estimates for the next years, SAN will show a small growth in Revenue. The Revenue will grow by 4.52% on average per year.
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.79, the valuation of SAN can be described as very reasonable.
83.33% of the companies in the same industry are more expensive than SAN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SAN to the average of the S&P500 Index (25.89), we can say SAN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.43, the valuation of SAN can be described as reasonable.
81.48% of the companies in the same industry are more expensive than SAN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SAN to the average of the S&P500 Index (34.59), we can say SAN is valued rather cheaply.
Industry RankSector Rank
PE 11.79
Fwd PE 10.43
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

SAN's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, SAN is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.67
EV/EBITDA 11.49
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of SAN may justify a higher PE ratio.
PEG (NY)3.84
PEG (5Y)2.31
EPS Next 2Y5.75%
EPS Next 3Y6.01%

8

5. Dividend

5.1 Amount

SAN has a Yearly Dividend Yield of 4.33%, which is a nice return.
Compared to an average industry Dividend Yield of 3.01, SAN pays a better dividend. On top of this SAN pays more dividend than 87.04% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.33%

5.2 History

The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SAN pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
The dividend of SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
SAN.PA Dividend Payout.SAN.PA Dividend Payout, showing the Payout Ratio.SAN.PA Dividend Payout.PayoutRetained Earnings

SANOFI

EPA:SAN (11/14/2025, 7:00:00 PM)

89.59

-0.85 (-0.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap218.24B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target106.43 (18.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.33%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-2.95%
PT rev (3m)-2.48%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-6.91%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-4.9%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)-0.47%
Valuation
Industry RankSector Rank
PE 11.79
Fwd PE 10.43
P/S 3.21
P/FCF 21.67
P/OCF 19.18
P/B 3.12
P/tB 23.48
EV/EBITDA 11.49
EPS(TTM)7.6
EY8.48%
EPS(NY)8.59
Fwd EY9.59%
FCF(TTM)4.13
FCFY4.61%
OCF(TTM)4.67
OCFY5.21%
SpS27.87
BVpS28.74
TBVpS3.82
PEG (NY)3.84
PEG (5Y)2.31
Graham Number70.1
Profitability
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROCE 16.7%
ROIC 13.84%
ROICexc 16.48%
ROICexgc 66.95%
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
FCFM 14.83%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 58.05%
Profit Quality 72.91%
Current Ratio 1.27
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC7.73%
ROIC/WACC1.79
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%

SANOFI / SAN.PA FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 6 / 10 to SAN.PA.


What is the valuation status for SAN stock?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.


What is the profitability of SAN stock?

SANOFI (SAN.PA) has a profitability rating of 7 / 10.


What is the expected EPS growth for SANOFI (SAN.PA) stock?

The Earnings per Share (EPS) of SANOFI (SAN.PA) is expected to grow by 3.07% in the next year.


How sustainable is the dividend of SANOFI (SAN.PA) stock?

The dividend rating of SANOFI (SAN.PA) is 8 / 10 and the dividend payout ratio is 34.82%.